Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Increased resistance of gram-negative urinary pathogens after kidney transplantation

Authors: Johannes Korth, Julia Kukalla, Peter-Michael Rath, Sebastian Dolff, Marco Krull, Hana Guberina, Anja Bienholz, Benjamin Wilde, Stefan Becker, Birgit Ross, Olympia Evdoxia Anastasiou, Andreas Kribben, Oliver Witzke

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Urinary tract infection is the most common complication after kidney transplantation. It can cause severe sepsis and transplant loss. Emergence of drug resistance among gram-negative urinary pathogens is the current challenge for urinary tract infection treatment after kidney transplantation.

Methods

This study analyzes the antimicrobial susceptibility of gram-negative urinary pathogens after kidney transplantation from 2009 to 2012 at the Transplant Outpatient Clinic of the University Hospital Essen, Germany. Kidney transplant patients at the University Hospital Essen receive regular follow up examinations after transplantation. Midstream urines were examined for bacteriuria at each follow up visit.

Results

From 2009 to 2012 15.741 urine samples were obtained from 859 patients. In 2985 (19%) samples bacterial growth was detected. The most frequently detected gram-negative bacteria were E.coli 1109 (37%), Klebsiella spp. 242 (8%) and Pseudomonas aeruginosa 136 (4.5%). Klebsiella spp. showed a significant increase of resistance to trimethoprim-sulfamethoxazole by 19% (p = 0.02), ciprofloxacin by 15% (p = 0.01) and ceftazidime by 17% (p = 0.004). E.coli and P. aeruginosa isolates presented no significant differences of antimicrobial susceptibility to the analyzed antibiotics.

Conclusions

Antimicrobial resistance of Klebsiella spp. increased significant to trimethoprim-sulfamethoxazole, ciprofloxacin and ceftazidime from 2009 to 2012.
Literature
1.
go back to reference Adamska Z, Karczewski M, Cichańska L, Więckowska B, Małkiewicz T, Mahadea D, et al. Bacterial infections in renal transplant recipients. Transplant Proc. 2015;47:1808–12.CrossRefPubMed Adamska Z, Karczewski M, Cichańska L, Więckowska B, Małkiewicz T, Mahadea D, et al. Bacterial infections in renal transplant recipients. Transplant Proc. 2015;47:1808–12.CrossRefPubMed
2.
go back to reference Lyerová L, Viklický O, Nemcová D, Teplan V. The incidence of infectious diseases after renal transplantation: a single-centre experience. Int J Antimicrob Agents. 2008;31(Suppl 1):S58–62.CrossRefPubMed Lyerová L, Viklický O, Nemcová D, Teplan V. The incidence of infectious diseases after renal transplantation: a single-centre experience. Int J Antimicrob Agents. 2008;31(Suppl 1):S58–62.CrossRefPubMed
3.
go back to reference Witzke O, Schmidt C, Kohnle M, Lütkes P, Philipp T, Heemann U. Impact of febrile infections on the long-term function of kidney allografts. J Urol. 2001;166:2048–52.CrossRefPubMed Witzke O, Schmidt C, Kohnle M, Lütkes P, Philipp T, Heemann U. Impact of febrile infections on the long-term function of kidney allografts. J Urol. 2001;166:2048–52.CrossRefPubMed
4.
go back to reference Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D, et al. Infective complications in renal allograft recipients: epidemiology and outcome. Transplant Proc. 2008;40:1873–6. Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D, et al. Infective complications in renal allograft recipients: epidemiology and outcome. Transplant Proc. 2008;40:1873–6.
5.
go back to reference Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transpl. 2005;19:230–5.CrossRef Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transpl. 2005;19:230–5.CrossRef
6.
go back to reference Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation. 2013;96:843–9.CrossRefPubMed Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation. 2013;96:843–9.CrossRefPubMed
7.
go back to reference Kuo H-T, Ye X, Sampaio MS, Reddy P, Bunnapradist S. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Transplantation. 2010;90:1091–8.CrossRefPubMed Kuo H-T, Ye X, Sampaio MS, Reddy P, Bunnapradist S. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Transplantation. 2010;90:1091–8.CrossRefPubMed
8.
go back to reference Bergamasco MD, Barroso Barbosa M, de Oliveira GD, Cipullo R, Moreira JCM, Baia C, et al. Infection with Klebsiella Pneumoniae carbapenemase (KPC)-producing K. Pneumoniae in solid organ transplantation. Transpl Infect Dis. 2012;14:198–205.CrossRefPubMed Bergamasco MD, Barroso Barbosa M, de Oliveira GD, Cipullo R, Moreira JCM, Baia C, et al. Infection with Klebsiella Pneumoniae carbapenemase (KPC)-producing K. Pneumoniae in solid organ transplantation. Transpl Infect Dis. 2012;14:198–205.CrossRefPubMed
9.
go back to reference de Gouvêa EF, Martins IS, Halpern M, Ferreira ALP, Basto ST, Gonçalves RT, et al. The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter Baumannii infection. BMC Infect Dis. 2012;12:351.CrossRefPubMedPubMedCentral de Gouvêa EF, Martins IS, Halpern M, Ferreira ALP, Basto ST, Gonçalves RT, et al. The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter Baumannii infection. BMC Infect Dis. 2012;12:351.CrossRefPubMedPubMedCentral
10.
go back to reference Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. A retrospective study of risk factors for carbapenem-resistant Klebsiella Pneumoniae acquisition among ICU patients. J Infect Dev Ctries. 2016;10:208–13.CrossRefPubMed Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. A retrospective study of risk factors for carbapenem-resistant Klebsiella Pneumoniae acquisition among ICU patients. J Infect Dev Ctries. 2016;10:208–13.CrossRefPubMed
11.
go back to reference Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Treated asymptomatic bacteriuria during first year after renal transplantation. Transpl Infect Dis. 2014;16:605–15.CrossRefPubMed Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Treated asymptomatic bacteriuria during first year after renal transplantation. Transpl Infect Dis. 2014;16:605–15.CrossRefPubMed
12.
go back to reference Pilmis B, Scemla A, Join-Lambert O, Mamzer M-F, Lortholary O, Legendre C, et al. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence. Infect Dis (London, England). 2015;47:714–8. Pilmis B, Scemla A, Join-Lambert O, Mamzer M-F, Lortholary O, Legendre C, et al. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence. Infect Dis (London, England). 2015;47:714–8.
13.
go back to reference Becker S, Witzke O, Rübben H, Kribben A. Harnwegsinfektionen nach Nierentransplantation. Urologe. 2011;50:53–6.CrossRefPubMed Becker S, Witzke O, Rübben H, Kribben A. Harnwegsinfektionen nach Nierentransplantation. Urologe. 2011;50:53–6.CrossRefPubMed
14.
go back to reference Senger SS, Arslan H, Azap OK, Timurkaynak F, Cağir U, Haberal M. Urinary tract infections in renal transplant recipients. Transplant Proc. 2007;39:1016–7.CrossRefPubMed Senger SS, Arslan H, Azap OK, Timurkaynak F, Cağir U, Haberal M. Urinary tract infections in renal transplant recipients. Transplant Proc. 2007;39:1016–7.CrossRefPubMed
15.
go back to reference Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc. 2006;38:2414–5.CrossRefPubMed Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc. 2006;38:2414–5.CrossRefPubMed
16.
go back to reference Origüen J, Fernández-Ruiz M, López-Medrano F, Ruiz-Merlo T, González E, Morales JM, et al. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options. Transpl Infect Dis. 2016;18:575–84.CrossRefPubMed Origüen J, Fernández-Ruiz M, López-Medrano F, Ruiz-Merlo T, González E, Morales JM, et al. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options. Transpl Infect Dis. 2016;18:575–84.CrossRefPubMed
17.
go back to reference Parasuraman R, Julian K. Urinary tract infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):327–36.CrossRefPubMed Parasuraman R, Julian K. Urinary tract infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):327–36.CrossRefPubMed
18.
go back to reference Pellé G, Vimont S, Levy PP, Hertig A, Ouali N, Chassin C, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant. 2007;7:899–907.CrossRefPubMed Pellé G, Vimont S, Levy PP, Hertig A, Ouali N, Chassin C, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant. 2007;7:899–907.CrossRefPubMed
19.
go back to reference Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, et al. Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients. Am J Transplant. 2015;15:1021–7.CrossRefPubMed Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, et al. Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients. Am J Transplant. 2015;15:1021–7.CrossRefPubMed
20.
go back to reference Rossignol L, Vaux S, Maugat S, Blake A, Barlier R, Heym B, et al. Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study. Infection (Springer Berlin Heidelberg). 2017;45:33–40. Rossignol L, Vaux S, Maugat S, Blake A, Barlier R, Heym B, et al. Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study. Infection (Springer Berlin Heidelberg). 2017;45:33–40.
22.
go back to reference Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and Pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (Oxford University Press). 2011;52:e103–20.CrossRef Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and Pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (Oxford University Press). 2011;52:e103–20.CrossRef
23.
go back to reference Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years. World J Urol. 2016;34(7):1031–7. Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years. World J Urol. 2016;34(7):1031–7.
25.
go back to reference Filius PMG, Gyssens IC, Kershof IM, Roovers PJE, Ott A, Vulto AG, et al. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother. 2005;49:2879–86.CrossRefPubMedPubMedCentral Filius PMG, Gyssens IC, Kershof IM, Roovers PJE, Ott A, Vulto AG, et al. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother. 2005;49:2879–86.CrossRefPubMedPubMedCentral
26.
go back to reference Tsai M-H, Chu S-M, Hsu J-F, Lien R, Huang H-R, Chiang M-C, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics. 2014;133:e322–9.CrossRefPubMed Tsai M-H, Chu S-M, Hsu J-F, Lien R, Huang H-R, Chiang M-C, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics. 2014;133:e322–9.CrossRefPubMed
27.
go back to reference Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia Coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother. 2012;56:2181–3.CrossRefPubMedPubMedCentral Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia Coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother. 2012;56:2181–3.CrossRefPubMedPubMedCentral
28.
go back to reference Yang Y-S, Ku C-H, Lin J-C, Shang S-T, Chiu C-H, Yeh K-M, et al. Impact of extended-spectrum β-lactamase-producing Escherichia Coli and Klebsiella Pneumoniae on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect. 2010;43:194–9.CrossRefPubMed Yang Y-S, Ku C-H, Lin J-C, Shang S-T, Chiu C-H, Yeh K-M, et al. Impact of extended-spectrum β-lactamase-producing Escherichia Coli and Klebsiella Pneumoniae on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect. 2010;43:194–9.CrossRefPubMed
29.
go back to reference Espinar MJ, Miranda IM, Costa-De-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C. Urinary tract infections in kidney transplant patients due to Escherichia Coli and Klebsiella Pneumoniae-producing extended-spectrum β-lactamases: risk factors and molecular epidemiology. PLoS One. 2015;10:1–11.CrossRef Espinar MJ, Miranda IM, Costa-De-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C. Urinary tract infections in kidney transplant patients due to Escherichia Coli and Klebsiella Pneumoniae-producing extended-spectrum β-lactamases: risk factors and molecular epidemiology. PLoS One. 2015;10:1–11.CrossRef
30.
go back to reference Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents. 2003;22(Suppl 2):49–52.CrossRefPubMed Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents. 2003;22(Suppl 2):49–52.CrossRefPubMed
31.
go back to reference Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125–32.CrossRefPubMed Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125–32.CrossRefPubMed
32.
go back to reference Origüen J, López-Medrano F, Fernández-Ruiz M, Polanco N, Gutiérrez E, González E, et al. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant. 2016;16:2943.CrossRefPubMed Origüen J, López-Medrano F, Fernández-Ruiz M, Polanco N, Gutiérrez E, González E, et al. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant. 2016;16:2943.CrossRefPubMed
34.
go back to reference Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T, et al. Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis. 2008;197:1094–102.CrossRefPubMedPubMedCentral Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T, et al. Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis. 2008;197:1094–102.CrossRefPubMedPubMedCentral
35.
go back to reference Iriart X, Challan Belval T, Fillaux J, Esposito L, Lavergne R-A, Cardeau-Desangles I, et al. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis. Am J Transplant. 2015;15:190–9.CrossRefPubMed Iriart X, Challan Belval T, Fillaux J, Esposito L, Lavergne R-A, Cardeau-Desangles I, et al. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis. Am J Transplant. 2015;15:190–9.CrossRefPubMed
36.
go back to reference Singh R, Bemelman FJ, Hodiamont CJ, Idu MM, Ten Berge IJM, Geerlings SE. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study. BMC Infect Dis (BioMed Central Ltd). 2016;16:90.CrossRef Singh R, Bemelman FJ, Hodiamont CJ, Idu MM, Ten Berge IJM, Geerlings SE. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study. BMC Infect Dis (BioMed Central Ltd). 2016;16:90.CrossRef
37.
go back to reference Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Urinary tract infections during the first year after renal transplantation: one center’s experience and a review of the literature. Clin Transpl. 2014;28:1263–70.CrossRef Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Urinary tract infections during the first year after renal transplantation: one center’s experience and a review of the literature. Clin Transpl. 2014;28:1263–70.CrossRef
38.
go back to reference Dharnidharka VR, Agodoa LY, Abbott KC. Effects of urinary tract infection on outcomes after renal transplantation in children. Clin J Am Soc Nephrol (American Society of Nephrology). 2006;2:100–6.CrossRef Dharnidharka VR, Agodoa LY, Abbott KC. Effects of urinary tract infection on outcomes after renal transplantation in children. Clin J Am Soc Nephrol (American Society of Nephrology). 2006;2:100–6.CrossRef
39.
40.
go back to reference Zalmanovici Trestioreanu A, Lador A, Sauerbrun-Cutler M-T, Leibovici L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. 2015;4:CD009534.PubMed Zalmanovici Trestioreanu A, Lador A, Sauerbrun-Cutler M-T, Leibovici L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. 2015;4:CD009534.PubMed
41.
go back to reference Singh R, Geerlings SE, Bemelman FJ. Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients. Curr Opin Infect Dis. 2015;28:112–6.CrossRefPubMed Singh R, Geerlings SE, Bemelman FJ. Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients. Curr Opin Infect Dis. 2015;28:112–6.CrossRefPubMed
42.
go back to reference Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, et al. Impact of urinary tract infections on short-term kidney graft outcome. Clin Microbiol Infect. 2015;21:1104.e1–8.CrossRef Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, et al. Impact of urinary tract infections on short-term kidney graft outcome. Clin Microbiol Infect. 2015;21:1104.e1–8.CrossRef
43.
go back to reference Lee JR, Bang H, Dadhania D, Hartono C, Aull MJ, Satlin M, et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation. 2013;96:732–8.CrossRefPubMed Lee JR, Bang H, Dadhania D, Hartono C, Aull MJ, Satlin M, et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation. 2013;96:732–8.CrossRefPubMed
Metadata
Title
Increased resistance of gram-negative urinary pathogens after kidney transplantation
Authors
Johannes Korth
Julia Kukalla
Peter-Michael Rath
Sebastian Dolff
Marco Krull
Hana Guberina
Anja Bienholz
Benjamin Wilde
Stefan Becker
Birgit Ross
Olympia Evdoxia Anastasiou
Andreas Kribben
Oliver Witzke
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0580-z

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue